IRIS
VIVIANI, GIORGIO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.016
AS - Asia 54
SA - Sud America 6
NA - Nord America 1
Totale 11.077
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.016
CN - Cina 35
SG - Singapore 19
BR - Brasile 4
AR - Argentina 1
CL - Cile 1
US - Stati Uniti d'America 1
Totale 11.077
Salva come PNG Salva come JPEG
Città #
Genova 6.755
Genoa 2.594
Rapallo 985
Vado Ligure 661
Bordighera 21
Beijing 14
Singapore 3
Ashburn 1
Bofete 1
Estación Colina 1
Inhambupe 1
Jardín América 1
Porto Alegre 1
Vila Velha 1
Totale 11.040
Salva come PNG Salva come JPEG
Nome #
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 206
Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus 195
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 182
An emerging role of glucagon-like Peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. 181
N-Acetyl-L-Cysteine Prevents Effects Of Pentosidine on the Pancreatic Beta-Cell Line HIT-T15 178
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 178
Insulin primes human neutrophils for CCL3-induced migration: crucial role for JNK 1/2. 173
Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15 171
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 167
Effects of valsartan therapy on protein glycoxidation. 166
Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis. 163
Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose. 162
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 161
Influence of cell age and ketoaminic linkage on rapid glycosylation of hemoglobin in human red cells in vitro. 157
Statins in the treatment of acute ischemic stroke. 157
Water distribution in insulin-dependent diabetes mellitus in various states of metabolic control. 154
New evidence for nicotinic acid treatment to reduce atherosclerosis. 152
An instrument for real-time spectral estimation of heart rate variability signals. 150
Advanced Glycation End-products affect subcellular localization of the transcription factors regulating insulin gene transcription. 150
Impairment of central motor conduction in diabetic patients. 147
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium. 147
Advanced glycation endproducts and diabetes. Beyond vascular complications. 144
Glucagon-Like Peptide-1 Triggers Protective Pathways in Pancreatic Beta-Cells Exposed to Glycated Serum. 141
Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus. 141
Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes. 140
Role of cytokines and chemokines in non-alcoholic fatty liver disease. 139
A method for erythrocyte filtration. 135
Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction. 135
I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects. 135
Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System 134
Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T15. 133
Analysis of non-fibroblastic interstitial cells of human pancreas. 133
Exploration of the early insulin response by two small successive loads of I.V. glucose in normal and obese subjects. 132
Bcl-2 family and caspase-3 gene expression in fas-mediated apoptosis of isolated rat islets. 127
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. 125
Effetti degli AGEs sulla Linea Cellulare HIT-T15 Insulino-secernente 124
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 123
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. 123
Retinal Pigment Epithelial Cells Express a Functional Receptor for Glucagon-Like Peptide-1 (GLP-1). 123
Response to anti-VEGF-A treatment of retinal pigment epithelial cells in vitro. 122
Response to anti-VEGF-A treatment of endothelial cells in vitro 119
Lercanidipine in type II diabetic patients with mild to moderate arterial hypertension. 119
null 116
[Psychological aspects in the therapy of diabetes]. 116
RANKL/OPG pathway is a promising target to reduce atherosclerosis plaque calcification. 115
Effects on glycation of Valsartan therapy in vivo. 114
GLP-1 PREVENTS AGEs-INDUCED PANCREATIC BETA CELL DYSFUNCTION. 113
Reduced glucose effectiveness as a feature of glucose intolerance evidence in elderly type-2 diabetic subjects. 113
Differente effetto ossidativo indotto da pentosidina e siero glicato ed efficacia del trattamento antiossidante con N-acetilcisteina su linee HIT-T15 e ARPE-19 112
Caveolin-1 is essential for glimepiride-induced insulin secretion in the pancreatic betaTC-6 cell line 111
Effects of advanced glycation end-products on GLP-1 secreting cells 103
[NEFA behavior and its correlations with IRI during IVGTT in normal, obese and diabetic subjects]. 103
Isolation of pig pancreatic islets by a new method with hydraulic shaking 102
Effect of nicotinic acid associated with retinol and tocopherols on plasma lipids in hyperlipoproteinaemic patients. 102
Azathioprine decreases insulin secretion in human islets. 100
Pioglitazone attenuates the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T15. 98
Repaglinide-metformin combination in the treatment of type 2 diabetes: Comparison between three different combination regimens. 97
Prednisolone protects pancreatic B-cells agaist cyclosporine and azathioprine effects. 96
Rat serum improves rat pseudoislet formation and insulin gene expression. 96
Indipendence of morphological and functional aspects of pseudoislets from gel collagen matrix. cell 95
Oral tolerance and allograft: can multiple oral administrations of low doses of highly purified islets induce periferal tolerance in pancreatic islets allograft? 94
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials 94
Application of the hydraulic shaking system to isolation of human pancreatic islets 94
RETINAL PIGMENT EPITHELIAL CELLS EXPRESS A FUNCTIONAL RECEPTOR FOR GLUCAGON-LIKE PEPTIDE-1. 91
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials. 91
Receptor activator of NF-kappa B ligand (RANKL) increases neutrophilic degranulation and potentially associated cardiovascular risk. 90
Glycated FBS affects the viability of an insulin-secreting cell line in vitro. 87
In beta-TC cells nicotinamide prevents IL-1 beta-induced apoptosis blocks caspase-3 activation and up-regulates Bcl-2 86
[Pathology of the periodontium in diabetes mellitus: possible pathogenetic correlations and therapeutic indications]. 85
The cannabinoid receptor type 2 is down-regulated in downstream portions of human carotid plaques. 85
Correlations between gamma-glutamyl-transpeptidase, triglycerides and cholesterol in normal, obese and diabetic subjects. 85
Long-term follow-up of human islet autotransplantation. 84
Type 2 diabetes in elderly: assessment and treatment. A review and personal observational data (part II). 83
Insulin response and NEFA behavior in volunteers with a flat response to oral glucose tolerance test. 81
Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization 81
Oxidative stress, homocysteine and platelet function in NIDDM patients 81
Glycated serum decrease insulin secretion of the pancreatic beta cell line HIT-T15 80
[Left ventricular diastolic function in type I diabetes. A longitudinal echocardiographic study]. 79
I problemi dell'anziano con un piede diabetico 78
GLUCOSE INTERORGAN EXCHANGE IN CHRONIC RENAL FAILURE 78
[Non-insulin-dependent diabetes mellitus in the young]. 78
Prevention of rejection and fibrosis: considerations in 25 patients. 78
Regulation of VEGF by pentosi dine and glycated serum 77
Correlations between NEFA and ketone bodies in normal and diabetic subjects. 75
L'approccio clinico-terapeutico al paziente diabetico anziano nelle diverse realtà assistenziali: revisione della letteratura ed esperienza personale (Seconda parte) 75
Differential effects of insulin on glycemia, NEFA and ketone bodies in diabetic subjects. 74
Double test of insulin sensitivity in normal and obese subjects. 73
Effects of pindolol in insulin secretion. II. OGTT changes after pindolol therapy. 72
[Insulin secretion and hepatic extraction in juvenile non-insulin-dependent diabetes]. 70
Examination of the early phase of insulin secretion with 3 successive small overloads of glucose (5 g) in normal and obese subjects. 69
Cardiac function in the insulin-dependent juvenile diabetic: evaluation with echocardiography, polygraphy and dynamic electrocardiography. 67
Special aspects of the curve of the oral glucose tolerance test. 66
Effects of pindolol on insulin secretion. I. Insulin response to small intravenous loads of glucose and to pindolol infusion. 66
Glycated Serum Decreases Insulin Content and Modifies the Expression of Proteins Involved in Insulin Granule Exocytosis. 65
Autonomous artificial intelligence versus teleophthalmology for diabetic retinopathy 64
Islet autotransplantation in humans--a model for allotransplantation. 64
Effects of normoglycemia after a low carbohydrate diet in NIDDM. Insulin secretion and effectiveness. 63
MiR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells 49
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study 49
Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury. 12
Totale 11.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.560
article - articoli 30.606
book - libri 0
conference - conferenze 2.954
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 0 0 0 55 29 33 40 57 69 74 37 47
2021/20221.174 37 78 40 180 56 90 83 265 34 117 35 159
2022/20231.195 115 73 13 113 227 206 0 91 219 9 107 22
2023/2024593 23 89 7 68 56 120 30 29 35 17 41 78
2024/20251.682 49 120 48 93 232 177 134 295 55 85 172 222
2025/2026859 376 63 184 236 0 0 0 0 0 0 0 0
Totale 11.159